FDA Inspection 1262011 — Vistin Pharma AS avd Kragero Fikkjebakke
The FDA completed an inspection of Vistin Pharma AS avd Kragero Fikkjebakke on January 31, 2025 in Sannidal. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 31, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sannidal (Norway)